Inhibition of JNK increases survival of transplanted dopamine neurons in Parkinsonian rats.
Rawal
N
N
Parish
C
C
Castelo-Branco
G
G
Arenas
E
E
D000818:Animals; D000873:Anthracenes / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D004195:Disease Models, Animal; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D006085:Graft Survival / Q000187:drug effects; D048031:JNK Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors*; D008636:Mesencephalon / Q000166:cytology / Q000187:drug effects; D009474:Neurons / Q000166:cytology / Q000187:drug effects / Q000201:enzymology* / Q000637:transplantation*; D010300:Parkinson Disease / Q000201:enzymology* / Q000473:pathology*; D051381:Rats; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
D000873:Anthracenes; C432165:pyrazolanthrone; D014446:Tyrosine 3-Monooxygenase; D048031:JNK Mitogen-Activated Protein Kinases; D004298:Dopamine